Blueprint Medicines
BPMC
#2524
Rank
S$7.56 B
Marketcap
$119.42
Share price
0.81%
Change (1 day)
72.76%
Change (1 year)

EPS for Blueprint Medicines (BPMC)

EPS in 2023 (TTM): -$12.38

According to Blueprint Medicines 's latest financial reports the company's current EPS (TTM) is -$11.97. In 2022 the company made an earnings per share (EPS) of -$12.18 an increase over its 2021 EPS that were of -$14.30.

EPS history for Blueprint Medicines from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$12.381.64%
2022-$12.18-14.85%
2021-$14.30-297.13%
2020$7.26-176.3%
2019-$9.5135.19%
2018-$7.0338.82%
2017-$5.0747.35%
2016-$3.449.25%
2015-$3.15-31.35%
2014-$4.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.09118-99.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.35-97.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.65-86.18%๐Ÿ‡บ๐Ÿ‡ธ USA